{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T08:18:17Z","timestamp":1768033097922,"version":"3.49.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Stomatology Oral and Maxillofacial Surgery"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.jormas.2025.102393","type":"journal-article","created":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T19:21:33Z","timestamp":1745868093000},"page":"102393","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"S","title":["Comparing the immune response of mRNA-based, inactivated COVID-19 and seasonal influenza vaccines and their effects on submandibular glands and associated lymph nodes in albino rats: biochemical, histological and immunohistochemical analysis"],"prefix":"10.1016","volume":"126","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2962-0070","authenticated-orcid":false,"given":"Nermeen","family":"AbuBakr","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rabab","family":"Mubarak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tahany","family":"Haggag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heba","family":"Khaled","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1142","key":"10.1016\/j.jormas.2025.102393_bib0001","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1136\/postgradmedj-2020-138234","article-title":"Origin, transmission, diagnosis and management of coronavirus disease 2019 (COVID-19)","volume":"96","author":"Umakanthan","year":"2020","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.jormas.2025.102393_bib0002","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.cca.2020.05.044","article-title":"COVID-19: transmission, prevention, and potential therapeutic opportunities","volume":"508","author":"Lotfi","year":"2020","journal-title":"Clin Chim Acta"},{"issue":"1","key":"10.1016\/j.jormas.2025.102393_bib0003","doi-asserted-by":"crossref","DOI":"10.5812\/ijpr.124228","article-title":"Review on approved and inprogress COVID-19 vaccines","volume":"21","author":"Farnudian-Habibi","year":"2022","journal-title":"Iran J Pharm Res"},{"issue":"27","key":"10.1016\/j.jormas.2025.102393_bib0004","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.jormas.2025.102393_bib0005","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1084\/jem.20171450","article-title":"Nucleoside-modified mRNA vaccines induce potent T follicular helper and germinal center B cell responses","volume":"215","author":"Pardi","year":"2018","journal-title":"J Exp Med"},{"issue":"6","key":"10.1016\/j.jormas.2025.102393_bib0006","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S1473-3099(20)30987-7","article-title":"Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy adults aged 60 years and older: a randomised, double-blind, placebo-controlled, phase 1\/2 clinical trial","volume":"21","author":"Wu","year":"2021","journal-title":"Lancet Infect Dis"},{"issue":"39","key":"10.1016\/j.jormas.2025.102393_bib0007","doi-asserted-by":"crossref","first-page":"5825","DOI":"10.1016\/j.vaccine.2019.08.016","article-title":"Safety and immunogenicity of high-dose quadrivalent influenza vaccine in adults \u226565 years of age: a phase 3 randomized clinical trial","volume":"37","author":"Chang","year":"2019","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.jormas.2025.102393_bib0008","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/j.vaccine.2011.12.098","article-title":"Public health impact of including two lineages of influenza B in a quadrivalent seasonal influenza vaccine","volume":"30","author":"Reed","year":"2012","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.jormas.2025.102393_bib0009","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12982-024-00140-x","article-title":"Evolution and implications of SARS-CoV-2 variants in the post-pandemic era","volume":"21","author":"Manirambona","year":"2024","journal-title":"Discover Public Health"},{"issue":"2","key":"10.1016\/j.jormas.2025.102393_bib0010","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S1473-3099(20)30843-4","article-title":"Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18-59 years: a randomised, double-blind, placebo-controlled, phase 1\/2 clinical trial","volume":"21","author":"Zhang","year":"2021","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"10.1016\/j.jormas.2025.102393_bib0011","doi-asserted-by":"crossref","first-page":"392","DOI":"10.4049\/jimmunol.1801054","article-title":"Development of a universal influenza vaccine","volume":"202","author":"Estrada","year":"2019","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.jormas.2025.102393_bib0012","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2024.2333104","article-title":"Comparison of T cells mediated immunity and side effects of mRNA vaccine and conventional COVID-19 vaccines administrated in Jordan","volume":"20","author":"Jaber","year":"2024","journal-title":"Hum Vaccin Immunother"},{"issue":"2","key":"10.1016\/j.jormas.2025.102393_bib0013","doi-asserted-by":"crossref","first-page":"417","DOI":"10.3390\/vaccines11020417","article-title":"Toxicological assessments of a pandemic COVID-19 vaccine-demonstrating the suitability of a platform approach for mRNA vaccines","volume":"11","author":"Rohde","year":"2023","journal-title":"Vaccines (Basel)"},{"issue":"2","key":"10.1016\/j.jormas.2025.102393_bib0014","doi-asserted-by":"crossref","first-page":"206","DOI":"10.3390\/pharmaceutics13020206","article-title":"Lipid nanoparticles as delivery systems for RNA-based vaccines","volume":"13","author":"Aldosari","year":"2021","journal-title":"Pharmaceutics"},{"issue":"2","key":"10.1016\/j.jormas.2025.102393_bib0015","doi-asserted-by":"crossref","first-page":"327","DOI":"10.23812\/CONTI-E","article-title":"Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategies","volume":"34","author":"Conti","year":"2020","journal-title":"J Biol Regul Homeost Agents"},{"issue":"11","key":"10.1016\/j.jormas.2025.102393_bib0016","article-title":"A comparative characterization of SARS-CoV-2-specific T cells induced by mRNA or inactive virus COVID-19 vaccines","volume":"3","author":"Lim","year":"2022","journal-title":"Cell Rep Med"},{"issue":"7855","key":"10.1016\/j.jormas.2025.102393_bib0017","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/s41586-021-03324-6","article-title":"mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants","volume":"592","author":"Wang","year":"2021","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.jormas.2025.102393_bib0018","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S1473-3099(20)30831-8","article-title":"Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1\/2 trial","volume":"21","author":"Xia","year":"2021","journal-title":"Lancet Infec Dis"},{"issue":"12","key":"10.1016\/j.jormas.2025.102393_bib0019","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1016\/S1473-3099(21)00319-4","article-title":"Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy children and adolescents: a double-blind, randomised, controlled, phase 1\/2 clinical trial","volume":"21","author":"Han","year":"2021","journal-title":"Lancet Infec Dis"},{"issue":"2","key":"10.1016\/j.jormas.2025.102393_bib0020","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S1473-3099(21)00462-X","article-title":"Safety and immunogenicity of an inactivated COVID-19 vaccine, BBIBP-CorV, in people younger than 18 years: a randomised, double-blind, controlled, phase 1\/2 trial","volume":"22","author":"Xia","year":"2021","journal-title":"Lancet Infec Dis"},{"issue":"1","key":"10.1016\/j.jormas.2025.102393_bib0021","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/21645515.2021.1885278","article-title":"Immunogenicity and safety of two quadrivalent influenza vaccines in healthy adult and elderly participants in India - A phase III, active-controlled, randomized clinical study","volume":"18","author":"Basu","year":"2022","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.jormas.2025.102393_bib0022","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.744887","article-title":"The mucosal and serological immune responses to the novel coronavirus (SARS-CoV-2) vaccines","volume":"12","author":"Chan","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jormas.2025.102393_bib0023","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.addr.2020.06.019","article-title":"Controlling timing and location in vaccines","volume":"158","author":"Irvine","year":"2020","journal-title":"Adv Drug Deliv Rev"},{"issue":"25","key":"10.1016\/j.jormas.2025.102393_bib0024","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1056\/NEJMoa2027906","article-title":"Safety and immunogenicity of two RNA-based covid-19 vaccine candidates","volume":"383","author":"Walsh","year":"2020","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.jormas.2025.102393_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.103656","article-title":"Early expansion of CD38+ICOS+ GC Tfh in draining lymph nodes during influenza vaccination immune response","volume":"25","author":"Law","year":"2022","journal-title":"iScience"},{"issue":"7","key":"10.1016\/j.jormas.2025.102393_bib0026","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S1473-3099(21)00224-3","article-title":"Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: a prospective observational study","volume":"21","author":"Menni","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jormas.2025.102393_bib0027","article-title":"Oral adverse events following COVID-19 vaccination: analysis of VAERS reports","volume":"10","author":"Riad","year":"2022","journal-title":"Front Public Heal"},{"issue":"2","key":"10.1016\/j.jormas.2025.102393_bib0028","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.annonc.2021.10.014","article-title":"Seroconversion rate after vaccination against COVID-19 in patients with cancer-a systematic review","volume":"33","author":"Corti","year":"2022","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jormas.2025.102393_bib0029","doi-asserted-by":"crossref","DOI":"10.12659\/AJCR.937212","article-title":"Unusual case of painful glossitis and xerostomia following vaccination with Pfizer-BioNTech SARS-CoV-2 (BNT162b2)","volume":"23","author":"Tan","year":"2022","journal-title":"Am J Case Rep"},{"key":"10.1016\/j.jormas.2025.102393_bib0030","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ijid.2019.12.010","article-title":"Immunogenicity and safety of quadrivalent versus trivalent inactivated subunit influenza vaccine in children and adolescents: a phase III randomized study","volume":"92","author":"Vesikari","year":"2020","journal-title":"Int J Infect Dis"}],"container-title":["Journal of Stomatology Oral and Maxillofacial Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S246878552500179X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S246878552500179X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T04:37:29Z","timestamp":1768019849000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S246878552500179X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S246878552500179X"],"URL":"https:\/\/doi.org\/10.1016\/j.jormas.2025.102393","relation":{},"ISSN":["2468-7855"],"issn-type":[{"value":"2468-7855","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparing the immune response of mRNA-based, inactivated COVID-19 and seasonal influenza vaccines and their effects on submandibular glands and associated lymph nodes in albino rats: biochemical, histological and immunohistochemical analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Stomatology Oral and Maxillofacial Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jormas.2025.102393","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102393"}}